Incentives Through the Grant of Stock Acquisition Rights to Employees
First written in FY2023-Q2. 2 of 5 entries say "Advanced", first in FY2025-H1. Latest entry: 2026-10-16.
- 2026-10-16Advancedwww.nikkei.com
「GiXo Ltd.: Notice Concerning Completion of Payment for New Shares Issued as Restricted Stock Compensation」
Payment for new shares issued as restricted stock compensation has been completed, marking progress in the implementation of the employee share-based compensation program. - FY2025Partially exercised and expiredAnnual report
「First stock options: 200 shares exercised; fourth stock options: 12,000 shares expired」
Of the employee stock acquisition rights, 200 shares under the first series have been exercised, 12,000 shares under the fourth series have lapsed, and the remaining unconfirmed balance is 138,000 shares. - FY2025-H1AdvancedAnnual report
「The total number of shares issued increased by 3,057, and both stated capital and capital surplus increased by ¥1.546 million, as a result of a new share issuance as restricted stock compensation, with 18 October 2024 as the payment date.」
The company issued 3,057 shares as restricted stock compensation, advancing the implementation of share-based compensation for employees. - FY2024-Q1Implementation of restricted stock compensationAnnual report
「The total number of shares issued increased by 274 as a result of a new share issuance as restricted stock compensation, with 10 November 2023 as the payment date.」
Separately from the share acquisition rights granted to employees, the company disclosed the issuance of 274 new shares as restricted stock compensation. - FY2023-Q2First statedAnnual report
「Categories and number of recipients (people): Company employees, 19 Class, terms and number of shares underlying the share acquisition rights (shares): Common shares, 150,000 Exercise period for the share acquisition rights: From 29 December 2027 to 14 December 2032」
Based on a resolution dated 14 December 2022, the company granted the fourth series of share acquisition rights to 19 employees, covering 1,500 rights and 150,000 common shares. The exercise price is ¥1,230, and the exercise period runs from 29 December 2027 to 14 December 2032.